These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8930031)
41. N-glycolylneuraminic acid-containing GM1 is a new molecule for serum antibody in Guillain-Barré syndrome. Odaka M; Yuki N; Yoshino H; Kasama T; Handa S; Irie F; Hirabayashi Y; Suzuki A; Hirata K Ann Neurol; 1998 Jun; 43(6):829-34. PubMed ID: 9629854 [TBL] [Abstract][Full Text] [Related]
42. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera. Iwamori M; Shimomura J; Tsuyuhara S; Mogi M; Ishizaki S; Nagai Y J Biochem; 1983 Jul; 94(1):1-10. PubMed ID: 6619101 [TBL] [Abstract][Full Text] [Related]
43. Anti-GM1 IgG antibodies in Guillain-Barré syndrome: fine specificity is associated with disease severity. Lardone RD; Yuki N; Odaka M; Daniotti JL; Irazoqui FJ; Nores GA J Neurol Neurosurg Psychiatry; 2010 Jun; 81(6):629-33. PubMed ID: 19965859 [TBL] [Abstract][Full Text] [Related]
44. Lack of association between autism and anti-GM1 ganglioside antibody. Moeller S; Lau NM; Green PH; Hellberg D; Higgins JJ; Rajadhyaksha AM; Alaedini A Neurology; 2013 Oct; 81(18):1640-1. PubMed ID: 24068789 [TBL] [Abstract][Full Text] [Related]
45. Serum anti-GM1 and anti-GD1a antibodies in patients with motor neuron disease. Voumvourakis C; Rombos A; Konstantoulakis MM; Segditsa I; Papageorgiou C Acta Neurol Scand; 1992 Dec; 86(6):599-602. PubMed ID: 1481647 [TBL] [Abstract][Full Text] [Related]
46. The probable auto-antigenic role of lipids (anti-ganglioside antibodies) in the pathogenesis of Alzheimer's disease. Koutsouraki E; Hatzifilippou E; Michmizos D; Banaki T; Costa V; Baloyannis S J Alzheimers Dis; 2014; 42 Suppl 3():S163-6. PubMed ID: 24898654 [TBL] [Abstract][Full Text] [Related]
47. Variation of myelin basic protein and its antibody in serum in senile dementia patients. Ge W; Cheng Y; Zhang S; Ye S; Chen J; Wang R; Li C Chin Med Sci J; 2000 Mar; 15(1):28. PubMed ID: 12899395 [No Abstract] [Full Text] [Related]
48. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y; Matsumoto Y; Yuki N No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [TBL] [Abstract][Full Text] [Related]
49. Antibodies against gangliosides GM1 of patients with multiple sclerosis alter the response of neurons to synaptic activation. Sergeeva SS; Zaprianova E; Sotnikov OS; Deleva D; Filchev A; Sultanov B Dokl Biol Sci; 2004; 399():461-3. PubMed ID: 15717608 [No Abstract] [Full Text] [Related]